Keep your dog protected with the Nobivac® Canine 1-DAPPVL4 vaccine, a reliable way to safeguard them against multiple serious diseases, such as:
Shake the Nobivac® Lepto4 vial and transfer its contents to the Nobivac® Canine 1-DAPPv vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.
Inject one dose (1 mL) subcutaneously.
The initial dose may be given at 8 weeks of age or older. Repeat at 2
to 4 week intervals until the dog is 12 weeks of age. A minimum of two
doses is required for primary immunization.
• Contains gentamicin and amphotericin B as preservatives.
• Vaccinate only healthy, non-parasitized dogs.
• Do not vaccinate pregnant bitches.
• The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
• The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch’s titer and quantity of colostral antibodies absorbed by the puppy.
Nobivac Canine 1-DAPPv+L4 is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.
Click here for our Vaccine Shipping Schedule.